ARISTOTLE CORP
SC 13D/A, 2000-02-15
WOMEN'S, MISSES', CHILDREN'S & INFANTS' UNDERGARMENTS
Previous: LOTUS PACIFIC INC, 10-Q, 2000-02-15
Next: PROGRESS FINANCIAL CORP, SC 13G/A, 2000-02-15




                                             PAGE  1 of  12 PAGES


                          UNITED STATES
               SECURITIES AND EXCHANGE COMMISSION
                     Washington, D.C. 20549

                          SCHEDULE 13D

           Under the Securities Exchange Act of 1934

                        (Amendment No. 7)

                    THE ARISTOTLE CORPORATION
                        (Name of Issuer)

            Common Stock, par value $0.01 per share
                    (Title of Class of Securities)

                           040 448201
                         (Cusip Number)

                        David T. Kettig
                     96 Cummings Point Road
              Stamford, CT 06902  (203)  358-8000
         (Name, Address and Telephone Number of Person
       Authorized to Receive Notices and Communications)

                        February 9, 2000
    (Date of Event which Requires Filing of this Statement)

If  the  filing  person  has previously  filed  a  statement  on
Schedule  13G to report the acquisition which is the subject  of
this  Schedule 13D, and is filing this schedule because of  Rule
13d-1 (b)(3) or (4), check the following box [  ].

Note:  Six  copies  of this statement, including  all  exhibits,
should be filed with the Commission. See Rule 13d-1(a) for other
parties to whom copies are to be sent.

*The  remainder  of this cover page shall be filled  out  for  a
reporting  person's initial filing on this form with respect  to
the   subject  class  of  securities,  and  for  any  subsequent
amendment  containing information which would alter  disclosures
provided in a prior cover page.

The  information  required on the remainder of this  cover  page
shall not be deemed to be "filed" for the purpose of Section  18
of  the  Securities  Exchange Act of 1934 ("Act")  or  otherwise
subject to the liabilities of that section or the Act but  shall
be  subject to all other provisions of the Act (however, see the
Notes).

Cusip No. 040 448201

<PAGE>

                                              PAGE 2 OF 12 PAGES

1.   NAMES OF REPORTING PERSON
      S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

          Geneve Corporation

2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                             (a) [   ]
                                             (b) [   ]

3.   SEC USE ONLY

4.   SOURCE OF FUNDS*
     WC

5.   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
     PURSUANT TO ITEMS 2(d) OR 2(e)         [  ]

6.   CITIZENSHIP OR PLACE OF ORGANIZATION
          DELAWARE

NUMBER              7. SOLE VOTING POWER
OF SHARES                724,813 SHARES
BENEFICIALLY             -------
OWNED BY EACH       8. SHARED VOTING POWER
REPORTING                    0   SHARES    (See Item 5)
PERSON WITH              -------
                    9. SOLE DISPOSITIVE POWER
                         724,813 SHARES
                         -------
                    10.SHARED DISPOSITIVE POWER
                             0   SHARES    (See Item 5)
                         -------
11.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     724,813 SHARES

12.  CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
     CERTAIN SHARES*
                                             [ ]

13.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
     40.1%

14.  TYPE OF REPORTING PERSON*

     CO

*SEE INSTRUCTIONS

<PAGE>
                                           PAGE  3 OF  12 PAGES


Item 1.   Security and Issuer.
          --------------------
      The undersigned hereby supplements and amends the Schedule
13D,   dated  January  9,  1998  (the  "Statement"),  filed   in
connection  with  the  Common Stock, par value  $.01  per  share
("Common  Stock"),  of  The Aristotle  Corporation,  a  Delaware
corporation (the "Company"), as follows (reference  is  made  to
the Statement for previously reported facts):

Item 4. Purpose of Transaction.
        -----------------------
      Item  4  of  the Statement is hereby amended  to  add  the
following:

      "Pursuant  to a letter agreement dated February  9,  2000,
Geneve converted (i) $330,000 stated value of Series E Preferred
Stock into a promissory note of the Company payable to the order
of  Geneve  in  the  principal  amount  of  $330,000,  and  (ii)
$1,920,000 stated value of Series E Preferred Stock into 489,131
shares   of  Common  Stock.  Geneve's  rights  to  (A)   acquire
additional shares of securities of the Company, and (B) exercise
voting   rights  and  privileges  with  respect  to  shares   of
securities  which  it  owns are subject  to  the  terms  of  the
Preferred  Stock Purchase Agreement, as modified by  the  letter
agreement.

      In  addition, on February 9, 2000, Geneve converted 23,608
shares  of  Series F Preferred Stock, 4,053 shares of  Series  G
Preferred  Stock  and 29,148 shares of Series H Preferred  Stock
into an aggregate of 94,682 shares of Common Stock.

      Geneve  reserves the right to change its mind with respect
to any or all matters referred to in Item 4 of the Statement."

Item 5.   Interest in Securities of the Issuer.
          -------------------------------------
     Item  5  of the Statement is hereby amended in its entirety
to read as follows:

      "Geneve  is the beneficial owner of and has the  power  to
vote  and  dispose  of  724,813 shares  of  Common  Stock  which
constitute 40.1% of the outstanding Common Stock of the Company,
as  of  the  date of the information most recently available  to
Geneve.  As  noted in Item 2 hereof, Mr. Edward  Netter  may  be
deemed to be the controlling person of Geneve.

      On  January  2,  1998, Geneve acquired  from  the  Company
489,131  shares of Series E Preferred Stock at $4.60 per  share.
On  that  same  date,  Geneve acquired from the  Company  30,000
shares of Common Stock at $4.50 per share.

      On August 6, 1999, Geneve acquired 23,608 shares of Series
F  Preferred Stock at $10.00 per share in a private transaction.
Each  share  of  Series F Preferred Stock  is  convertible  into
1.6666667 shares of Common Stock.

<PAGE>
                                             PAGE 4 of 12 PAGES

      On January 3, 2000, Geneve acquired 4,053 shares of Series
G  Preferred Stock and 29,148 shares of Series H Preferred Stock
at  $10.00  per  share in private transactions.  Each  share  of
Series  G  Preferred  Stock  and Series  H  Preferred  Stock  is
convertible into 1.6666667 shares of Common Stock.

     On  February 9, 2000, Geneve converted (i) $330,000  stated
value of Series E Preferred Stock into a promissory note of  the
Company  payable to the order of Geneve in the principal  amount
of  $330,000,  and  (ii) $1,920,000 stated  value  of  Series  E
Preferred  Stock  into  489,131  shares  of  Common  Stock.   In
addition,  Geneve  converted  (a)  23,608  shares  of  Series  F
Preferred  Stock into 39,347 shares of Common Stock,  (b)  4,053
shares  of Series G Preferred Stock into 6,755 shares of  Common
Stock  and  (c) 29,148 shares of Series H Preferred  Stock  into
48,580 shares of Common Stock.

     To the best of its knowledge, except as otherwise described
in  the  Statement, neither Geneve nor any of  its  officers  or
directors beneficially owns any Common Stock, Series E Preferred
Stock,  Series  F Preferred Stock, Series G Preferred  Stock  or
Series  H  Preferred  Stock. In addition,  except  as  otherwise
described  in  the  Statement, neither Geneve  nor  any  of  its
officers or directors has effected any transaction in the Common
Stock,  Series  E  Preferred Stock, Series  F  Preferred  Stock,
Series G Preferred Stock or Series H Preferred Stock during  the
past sixty days."

Item 7. Material to be Filed as Exhibits.
        ---------------------------------
     A. Letter Agreement dated February 9, 2000 between the
Company and Geneve.

<PAGE>


                                              PAGE 5 OF 12 PAGES


Signature
- ---------
      After  reasonable inquiry and to the best of the knowledge
and  belief  of the undersigned, the undersigned certifies  that
the  information set forth in this Statement is  true,  complete
and correct.

                              GENEVE CORPORATION




                              By: /s/Steven B. Lapin
                                  ------------------
                                     Steven B. Lapin




February 15, 2000

<PAGE>
                                             PAGE 6 OF 12 PAGES


                                        February 9, 2000



Geneve Corporation
96 Cummings Point Road
Stamford, CT  06902

Attention:     Steven B. Lapin, President
          David T. Kettig, Esq.

Gentlemen:

     Reference is made to the Preferred Stock Purchase Agreement
(the "Agreement") entered into as of October 22, 1997, between
The Aristotle Corporation (the "Company") and Geneve Corporation
(the "Purchaser") pursuant to which, among other things, the
Purchaser acquired shares of Series E Convertible Preferred
Stock of the Company (the "Geneve Preferred Stock").  Unless
otherwise indicated, all capitalized terms used in this letter
shall have the same meaning as set forth in the Agreement or the
Certificate of Designation, as defined below.

     The Company has advised the Purchaser that, rather than
wait until the mandatory redemption date of December 31, 2007,
as provided in the Series E Convertible Preferred Stock
Certificate of Designation (the "Certificate of Designation"),
it would be beneficial to the Company for various reasons,
including, but not limited to, augmentation of the Company's
balance sheet and assistance with respect to the Company's tax
planning efforts, if the Purchaser would accelerate the
conversion (the "Conversion") of all of the Geneve Preferred
Stock.

     Accordingly, in order to induce the Purchaser to accelerate
the Conversion, the Company and the Purchaser hereby agree as
follows:

1.   Conversion Effectuated.  Effective immediately, the
  Purchaser hereby elects to convert (a) $330,000 stated value of
  the Geneve Preferred Stock into a Promissory Note to be issued
  by the Company in the principal amount of $330,000 (in the form
  attached hereto as Exhibit A), and (b) $1,920,000 stated value
  of the Geneve Preferred Stock into 489,131 shares of the
  Company's Common Stock.  To the extent that the terms of the
  Certificate of Designation and the terms of this letter differ,
  the terms of this letter shall prevail;

2.   Certificate of Designation Terminated  The Certificate of
  Designation shall be deemed null and void, there being no more
  shares of Series E Preferred Stock outstanding;

3.   The Agreement.  The Agreement shall remain in full force
  and effect provided, however, (A) Section 5.05 of the Agreement
  (i) shall terminate with respect to any limitation on the
  Purchaser's voting rights and privileges, effective immediately,
  except that it shall not terminate with respect to voting rights
  and privileges pertaining to the election of directors of the
  Company and the approval, ratification or confirmation of the
  appointment of the independent accountants for the Company
  (collectively, "Director/Auditor Voting Rights"),

<PAGE>
                                             PAGE 7 OF 12 PAGES



4.   and (ii) shall terminate with respect to Director/Auditor
  Voting Rights (a) as of January 1, 2002, and (b) at any time
  prior to January 1, 2002, if two designated representatives of
  the Purchaser (currently, Edward Netter and Steven B. Lapin) are
  not members of the Board of Directors of the Company, and (B)
  Section 5.06 of the Agreement shall terminate, effective
  immediately;

5.   Issuances of Stock. The Company shall not issue shares of
  stock (other than Excluded Shares) such that the issued and
  outstanding shares of the Company owned by the Purchaser
  represents less than 30% of the outstanding value of the stock
  of the Company at any testing date; provided, however, in the
  event that the Company issues any Excluded Shares which would
  cause the Purchaser to have less than 30% of the outstanding
  value of the stock of the Company at any testing date, the
  Purchaser shall have the right to purchase, as of the testing
  date, such number of shares of the Company's Common Stock from
  the Company at the then Fair Market Value thereof so that such
  Purchaser does not have less than 30% of the outstanding value
  of the stock of the Company at such testing date, provided,
  further, however, that the Purchaser has determined, in its sole
  discretion, that it is unable to purchase in the open market
  such shares of Common Stock at the Fair Market Value thereof as
  of the testing date (all of the foregoing within the meaning of
  Section 382 of the Internal Revenue Code of 1986 and the
  regulations pertaining thereto).  Further, the Company shall not
  issue shares of stock or rights, warrants or options entitling
  the holders thereof to subscribe for or purchase shares of stock
  such as to cause an ownership change (within the meaning of
  Section 382 of the Internal Revenue Code of 1986 and the
  regulations pertaining thereto).

     The Company is aware that the Purchaser is currently the
record holder of shares of Preferred Stock of the Company other
than shares of Series E Convertible Preferred Stock (the
"Strouse Group Preferred Stock"), which the Purchaser purchased
from the previous record holders of Strouse Group Preferred
Stock, and that the Purchaser has, contemporaneously herewith,
provided notice to the Company, in the form attached hereto as
Exhibit B, of its election to convert all of the shares of the
Strouse Group Preferred Stock of which it is a record holder
(namely, 56,809 shares) into 94,682 shares of the Company's
Common Stock.

     The Company has advised the members of its Board of
Directors that the Purchaser, in its capacity, immediately after
the Conversion, as the largest holder of shares of Common Stock
of the Company, desires to further assure the continuation of
John J. Crawford as the Chairman, President and Chief Executive
Officer of the Company.

<PAGE>
                                             PAGE 8 OF 12 PAGES



     If the foregoing is in conformity with your understanding
and agreed to, please sign below where indicated.

                                   Very truly yours,

                                   THE ARISTOTLE CORPORATION


                                   By:  /s/ John J. Crawford
                                        --------------------
                                        John J. Crawford
                                   Its: Chairman, President and
                                        Chief Executive Officer

The foregoing is in conformity with our understanding and agreed
to as of this 9th day of February, 2000.

                                   GENEVE CORPORATION

                                   (Record Holder of the Geneve
                                   Preferred Stock)


                                   By:  /s/ Steven B. Lapin
                                        -------------------
                                        Steven B. Lapin
                                   Its: President

<PAGE>

                                             PAGE 9 OF 12 PAGES


                                         EXHIBIT A

                        PROMISSORY NOTE


$330,000                                         February 9, 2000
- --------                                   New Haven, Connecticut


     FOR VALUE RECEIVED, The Aristotle Corporation (the
"Borrower") hereby promises to pay to the order of Geneve
Corporation (the "Lender"), a Delaware corporation, in lawful
money of the United States of America at the office of the
Lender at 96 Cummings Point Road, Stamford, Connecticut,  06902,
or at such other place or places or to such other party or
parties as the Lender may from time to time designate, the
principal sum of

        Three Hundred Thirty Thousand DOLLARS ($330,000)
        ------------------------------------------------
as follows:

     Principal.  The Borrower shall pay the entire principal
     balance of this Note on December 31, 2001;

     Interest.  Interest shall accrue on the outstanding
     principal balance of this Note at the rate of eight percent
     (8%) per annum, and shall be paid quarterly in arrears
     commencing March 31, 2000.

     It is the intent of the Lender and of the Borrower that in
no event shall interest be payable at a rate in excess of the
maximum rate permitted by applicable law (the "Maximum Legal
Rate").  Solely to the extent necessary to prevent interest
under this Note from exceeding the Maximum Legal Rate, any
amount that would be treated as excessive under a final judicial
interpretation of applicable law shall be deemed to have been a
mistake and automatically cancelled and, if received by the
Lender, shall be applied to the principal balance of this Note
or, if no principal balance remains outstanding, then such
amount shall be refunded to the Borrower.

     The Borrower may voluntarily prepay this Note in whole or
in part at any time and from time to time without penalty,
together with interest accrued on the amount prepaid through the
date of prepayment.

     Upon the occurrence of any one or more of the following
events (each, an "Event of Default"), the Lender at its option
may declare all amounts due hereunder, including, without
limitation, the entire unpaid principal balance of this Note and
any accrued, unpaid interest thereon, to be immediately due and
payable without notice or protest (both of which are hereby
waived):

     (a)  The failure to make any payment of principal or
     interest due pursuant to the terms of this Note on or
     before the due date;

<PAGE>
                                            PAGE 10 OF 12 PAGES


     (b)  (i) The commencement by the Borrower of a voluntary
     case under 11 U.S.C. '101 et. seq. (the "Bankruptcy Code")
     or any foreign, federal or state bankruptcy, insolvency or
     other similar law now or hereafter in effect, or (ii) the
     consent by the Borrower to the entry of an order for relief
     in an involuntary bankruptcy or similar case, or to the
     conversion of an involuntary case to a voluntary case,
     under any such law, or (iii) the consent by the Borrower to
     the appointment of, or the taking of possession by, a
     receiver, trustee or other custodian for all or a
     substantial part of its properties, or (iv) the making by
     the Borrower of any assignment for the benefit of
     creditors, or (v) the admission by the Borrower in writing
     of its inability to pay its debts as such debts become due,
     or (vi) the discontinuance of business, dissolution,
     winding up, liquidation or cessation of existence by the
     Borrower; or

     (c)  (i)  The entry by a court of a decree or order for
     relief with respect to the Borrower in an involuntary case
     under the Bankruptcy Code or any applicable foreign,
     federal or state bankruptcy, insolvency or other similar
     law now or hereafter in effect, which decree or order is
     not stayed or dismissed within 60 days of the entry
     thereof, or (ii) the entry by a court of a decree or order
     for the appointment of a receiver, liquidator,
     sequestrator, trustee, custodian or other person having
     similar powers over the Borrower or over all or a
     substantial part of its properties.

     Upon the occurrence and continuance of any Event of Default
hereunder, (i) the Lender may declare the principal balance of
this Note to be immediately due and payable, provided, however,
in the case of an Event of Default described in paragraphs (b)
or (c) above, all amounts payable by the Borrower hereunder,
including, without limitation, the principal balance and all
accrued interest on this Note, shall automatically become
immediately due and payable, without notice, action or election
by the Lender, and (iii) the Lender may enforce any other rights
granted pursuant to this Note, any other document, or by
applicable law.  All of the rights of the Lender hereunder shall
be cumulative and not exclusive, and each of which may be
exercised singly, repetitively, in any combination, and in any
order.  The Lender's rights and remedies hereunder may be
exercised without resort or regard to any other source of
satisfaction of any liabilities owing by the Borrower to the
Lender.  No inconsistency between the default provisions of this
Note and any other agreement shall be deemed to create any
additional notice, cure or grace period or derogate from the
express terms of such provisions.

     Upon the occurrence of an Event of Default, the Borrower
agrees to pay on demand all out-of-pocket costs and expenses
(including, without limitation, reasonable attorneys' fees)
incurred or paid by the holder(s) hereof in collecting or
enforcing this Note.

     The Borrower hereby waives presentment, demand, protest or
notice of any kind in connection with this Note.  No failure on
the part of the Lender in exercising any right or remedy
hereunder, and no single, partial or delayed exercise by the
Lender of any right or remedy shall preclude the full and timely
exercise by the Lender at any time of any right or remedy of the
Lender hereunder without notice.  No course of dealing or other
conduct, no oral agreement or representation made by the Lender
or usage of trade shall operate as a waiver of any right or
remedy of the Lender.  This Note contains the entire agreement
between the parties with respect to the subject matter hereof,
and supersedes every course of dealing, other conduct, oral
agreement or representation previously made by the Lender.  In
the event that any court of competent jurisdiction shall
determine that any provision, or portion thereof, contained in

<PAGE>

                                             PAGE 11 OF 12 PAGES


this Note shall be unenforceable in any respect, then such
provision shall be deemed limited to the extent that such court
deems it enforceable, and the remaining provisions of this Note
shall nevertheless remain in full force and effect.

     None of the terms or provisions of this Note may be
excluded, modified, or amended except by a written instrument
duly executed on behalf of both the Borrower and the Lender
expressly referring hereto and setting forth the provision so
excluded, modified or amended.  No waiver or forbearance of any
of the rights and remedies of the Lender hereunder shall be
effective unless made specifically in a writing signed by the
Lender, and any such waiver or forbearance shall be effective
only in the specific instance and for the specific purpose for
which given.

     This Note shall be binding upon the Borrower and shall be
enforceable against the Borrower and its successors, and shall
inure to the benefit of the Lender and its successors, endorsees
and assigns.  The Borrower may not assign this Note or any
rights hereunder without the express written consent of the
Lender.

     THIS NOTE IS DELIVERED TO THE LENDER AT ITS PRINCIPAL
OFFICE IN STAMFORD, CONNECTICUT, SHALL BE GOVERNED BY, CONSTRUED
AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF
CONNECTICUT WITHOUT REGARD TO ITS PRINCIPLES OF CONFLICTS OF
LAWS, AND SHALL TAKE EFFECT AS A SEALED INSTRUMENT.  THE
BORROWER AND EACH ENDORSER AND GUARANTOR OF THIS NOTE SUBMIT TO
THE JURISDICTION OF THE COURTS OF THE STATE OF CONNECTICUT AND
OF THE UNITED STATES DISTRICT COURTS SITUATED THEREIN FOR ALL
PURPOSES WITH RESPECT TO THIS NOTE.

     THE BORROWER HEREBY EXPRESSLY, KNOWINGLY AND VOLUNTARILY
WAIVES ALL RIGHTS TO TRIAL BY JURY IN ANY ACTION OR PROCEEDING
ARISING OUT OF, IN CONNECTION WITH, OR RELATED TO THIS NOTE,
INCLUDING, WITHOUT LIMITATION, IN CONNECTION WITH ANY DEFENSE,
AFFIRMATIVE DEFENSE, COUNTERCLAIM OR THE LIKE ASSERTED AGAINST
THE LENDER.

     IN WITNESS WHEREOF, the Borrower has caused this Note to be
executed as an instrument under seal as of the date first above
written.


                              THE ARISTOTLE CORPORATION

                              BY:  /s/ John J. Crawford
                                   --------------------
                                   John J. Crawford

          Its:   Chairman, President and Chief Executive Officer

<PAGE>

                                             PAGE 12 OF 12 PAGES


                            EXHIBIT B

                  NOTICE OF ELECTION TO CONVERT
                  SHARES OF PREFERRED STOCK OF
                    THE ARISTOTLE CORPORATION

                        FEBRUARY 9, 2000



TO:  The Aristotle Corporation
     27 Elm Street
     New Haven, CT  06511
     Attention:  Paul M. McDonald, Secretary

      PLEASE  TAKE  NOTICE that Geneve Corporation,  the  record
holder  of  23,608  shares of Series F Preferred  Stock  of  The
Aristotle  Corporation  (the  "Corporation"),  4,053  shares  of
Series G Preferred Stock of the Corporation and 29,148 shares of
Series H Preferred Stock of the Corporation, or an aggregate  of
56,809  shares  of Preferred Stock (collectively,  the  "Strouse
Preferred  Shares"), does hereby elect, irrevocably, to  convert
the  Strouse Preferred Shares into an aggregate of 94,682 shares
of  Common Stock of the Corporation (representing 39,347  shares
of Common Stock upon conversion of the 23,608 shares of Series F
Preferred Stock; 6,755 shares of Common Stock upon conversion of
4,053  shares  of  Series  G Preferred Stock;  and  48,580  upon
conversion  of  29,148  shares of  Series  H  Preferred  Stock),
effective immediately.

     This  notice  is  being delivered to the Secretary  of  the
Corporation, but is effective as and when written.

     Dated as of the ninth day of February, 2000.

                                   GENEVE CORPORATION


                                   By: /s/ Steven B. Lapin
                                       -------------------
                                           Steven B. Lapin
                                   Its:    President







© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission